Calcium, phosphate and parathyroid metabolism in kidney transplanted patients.

C. Ambrus, M. Molnár, Maria Eszter Czira, L. Rosivall, Istvan Kiss, A. Remport, M. Szathmári, I. Mucsi

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

INTRODUCTION: Impaired kidney function is common in kidney-transplanted patients and complications of chronic kidney disease (CKD), such as mineral and bone disorders (MBD) are also prevalent in this population. Similarly to other stages of CKD, increasing evidence supports the association between MBD and cardiovascular risk after kidney transplantation as well. Still, little is known about the prevalence, clinical correlates of MBD and its management in transplanted patients. In this study, we aimed to examine the characteristics of MBD and its associations with clinical parameters in a large prevalent cohort of patients after kidney transplantation. METHODS: Nine hundred and ninety stable patients followed at a single kidney transplant outpatient clinic were included in the study. Detailed medical history, demographic data and routine laboratory results, including Ca, P and intact PTH were collected. Estimated GFR was calculated using the abbreviated MDRD formula, patients were stratified into three groups based on eGFR. Target levels for Ca, P and iPTH were based on CKD stages according to the NKF-K/DOQI guidelines. Standard statistical procedures, binomial and multinomial regressions were used in the analysis. RESULTS: The mean age was 51 years, 57% were males and 21% were diabetic, with 72 months (median) post-transplantation. Most of the patients were in CKD stage 3. Serum phosphorus showed strong negative correlation with graft function in CKD stages 4-5 (r = -0.633, P <0.001). Hyperphosphatemia was independently associated with the time spent on dialysis before transplantation, serum iPTH and CKD stages 4-5. iPTH showed negative correlation with eGFR in CKD stages 3-5 (rho = -0.289, P <0.001) and weak positive correlation with time spent on dialysis prior to transplant (rho = 0.114, P <0.001). Both hyperparathyroidism (42%) and relative hypoparathyroidism (15%) were frequent. The prescription of P-binders (6%) and vitamin D analogs (33%) was sporadic. CONCLUSION: Disturbances of bone and mineral metabolism after transplantation are prevalent and are strongly correlated with the kidney function, similarly to non-transplanted CKD patients. MBD in this population is not adequately managed.

Original languageEnglish
Pages (from-to)1029-1038
Number of pages10
JournalInternational Urology and Nephrology
Volume41
Issue number4
DOIs
Publication statusPublished - Dec 2009

Fingerprint

Chronic Renal Insufficiency
Minerals
Kidney
Bone and Bones
Transplantation
Transplants
Kidney Transplantation
Dialysis
Hyperphosphatemia
Hypoparathyroidism
calcium phosphate
Hyperparathyroidism
Ambulatory Care Facilities
Serum
Vitamin D
Phosphorus
Population
Prescriptions
Demography
Guidelines

ASJC Scopus subject areas

  • Nephrology
  • Urology

Cite this

Calcium, phosphate and parathyroid metabolism in kidney transplanted patients. / Ambrus, C.; Molnár, M.; Czira, Maria Eszter; Rosivall, L.; Kiss, Istvan; Remport, A.; Szathmári, M.; Mucsi, I.

In: International Urology and Nephrology, Vol. 41, No. 4, 12.2009, p. 1029-1038.

Research output: Contribution to journalArticle

@article{0e8156e9dbf345658305bd9e59ffe5bc,
title = "Calcium, phosphate and parathyroid metabolism in kidney transplanted patients.",
abstract = "INTRODUCTION: Impaired kidney function is common in kidney-transplanted patients and complications of chronic kidney disease (CKD), such as mineral and bone disorders (MBD) are also prevalent in this population. Similarly to other stages of CKD, increasing evidence supports the association between MBD and cardiovascular risk after kidney transplantation as well. Still, little is known about the prevalence, clinical correlates of MBD and its management in transplanted patients. In this study, we aimed to examine the characteristics of MBD and its associations with clinical parameters in a large prevalent cohort of patients after kidney transplantation. METHODS: Nine hundred and ninety stable patients followed at a single kidney transplant outpatient clinic were included in the study. Detailed medical history, demographic data and routine laboratory results, including Ca, P and intact PTH were collected. Estimated GFR was calculated using the abbreviated MDRD formula, patients were stratified into three groups based on eGFR. Target levels for Ca, P and iPTH were based on CKD stages according to the NKF-K/DOQI guidelines. Standard statistical procedures, binomial and multinomial regressions were used in the analysis. RESULTS: The mean age was 51 years, 57{\%} were males and 21{\%} were diabetic, with 72 months (median) post-transplantation. Most of the patients were in CKD stage 3. Serum phosphorus showed strong negative correlation with graft function in CKD stages 4-5 (r = -0.633, P <0.001). Hyperphosphatemia was independently associated with the time spent on dialysis before transplantation, serum iPTH and CKD stages 4-5. iPTH showed negative correlation with eGFR in CKD stages 3-5 (rho = -0.289, P <0.001) and weak positive correlation with time spent on dialysis prior to transplant (rho = 0.114, P <0.001). Both hyperparathyroidism (42{\%}) and relative hypoparathyroidism (15{\%}) were frequent. The prescription of P-binders (6{\%}) and vitamin D analogs (33{\%}) was sporadic. CONCLUSION: Disturbances of bone and mineral metabolism after transplantation are prevalent and are strongly correlated with the kidney function, similarly to non-transplanted CKD patients. MBD in this population is not adequately managed.",
author = "C. Ambrus and M. Moln{\'a}r and Czira, {Maria Eszter} and L. Rosivall and Istvan Kiss and A. Remport and M. Szathm{\'a}ri and I. Mucsi",
year = "2009",
month = "12",
doi = "10.1007/s11255-009-9631-0",
language = "English",
volume = "41",
pages = "1029--1038",
journal = "International Urology and Nephrology",
issn = "0301-1623",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Calcium, phosphate and parathyroid metabolism in kidney transplanted patients.

AU - Ambrus, C.

AU - Molnár, M.

AU - Czira, Maria Eszter

AU - Rosivall, L.

AU - Kiss, Istvan

AU - Remport, A.

AU - Szathmári, M.

AU - Mucsi, I.

PY - 2009/12

Y1 - 2009/12

N2 - INTRODUCTION: Impaired kidney function is common in kidney-transplanted patients and complications of chronic kidney disease (CKD), such as mineral and bone disorders (MBD) are also prevalent in this population. Similarly to other stages of CKD, increasing evidence supports the association between MBD and cardiovascular risk after kidney transplantation as well. Still, little is known about the prevalence, clinical correlates of MBD and its management in transplanted patients. In this study, we aimed to examine the characteristics of MBD and its associations with clinical parameters in a large prevalent cohort of patients after kidney transplantation. METHODS: Nine hundred and ninety stable patients followed at a single kidney transplant outpatient clinic were included in the study. Detailed medical history, demographic data and routine laboratory results, including Ca, P and intact PTH were collected. Estimated GFR was calculated using the abbreviated MDRD formula, patients were stratified into three groups based on eGFR. Target levels for Ca, P and iPTH were based on CKD stages according to the NKF-K/DOQI guidelines. Standard statistical procedures, binomial and multinomial regressions were used in the analysis. RESULTS: The mean age was 51 years, 57% were males and 21% were diabetic, with 72 months (median) post-transplantation. Most of the patients were in CKD stage 3. Serum phosphorus showed strong negative correlation with graft function in CKD stages 4-5 (r = -0.633, P <0.001). Hyperphosphatemia was independently associated with the time spent on dialysis before transplantation, serum iPTH and CKD stages 4-5. iPTH showed negative correlation with eGFR in CKD stages 3-5 (rho = -0.289, P <0.001) and weak positive correlation with time spent on dialysis prior to transplant (rho = 0.114, P <0.001). Both hyperparathyroidism (42%) and relative hypoparathyroidism (15%) were frequent. The prescription of P-binders (6%) and vitamin D analogs (33%) was sporadic. CONCLUSION: Disturbances of bone and mineral metabolism after transplantation are prevalent and are strongly correlated with the kidney function, similarly to non-transplanted CKD patients. MBD in this population is not adequately managed.

AB - INTRODUCTION: Impaired kidney function is common in kidney-transplanted patients and complications of chronic kidney disease (CKD), such as mineral and bone disorders (MBD) are also prevalent in this population. Similarly to other stages of CKD, increasing evidence supports the association between MBD and cardiovascular risk after kidney transplantation as well. Still, little is known about the prevalence, clinical correlates of MBD and its management in transplanted patients. In this study, we aimed to examine the characteristics of MBD and its associations with clinical parameters in a large prevalent cohort of patients after kidney transplantation. METHODS: Nine hundred and ninety stable patients followed at a single kidney transplant outpatient clinic were included in the study. Detailed medical history, demographic data and routine laboratory results, including Ca, P and intact PTH were collected. Estimated GFR was calculated using the abbreviated MDRD formula, patients were stratified into three groups based on eGFR. Target levels for Ca, P and iPTH were based on CKD stages according to the NKF-K/DOQI guidelines. Standard statistical procedures, binomial and multinomial regressions were used in the analysis. RESULTS: The mean age was 51 years, 57% were males and 21% were diabetic, with 72 months (median) post-transplantation. Most of the patients were in CKD stage 3. Serum phosphorus showed strong negative correlation with graft function in CKD stages 4-5 (r = -0.633, P <0.001). Hyperphosphatemia was independently associated with the time spent on dialysis before transplantation, serum iPTH and CKD stages 4-5. iPTH showed negative correlation with eGFR in CKD stages 3-5 (rho = -0.289, P <0.001) and weak positive correlation with time spent on dialysis prior to transplant (rho = 0.114, P <0.001). Both hyperparathyroidism (42%) and relative hypoparathyroidism (15%) were frequent. The prescription of P-binders (6%) and vitamin D analogs (33%) was sporadic. CONCLUSION: Disturbances of bone and mineral metabolism after transplantation are prevalent and are strongly correlated with the kidney function, similarly to non-transplanted CKD patients. MBD in this population is not adequately managed.

UR - http://www.scopus.com/inward/record.url?scp=77954913461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954913461&partnerID=8YFLogxK

U2 - 10.1007/s11255-009-9631-0

DO - 10.1007/s11255-009-9631-0

M3 - Article

VL - 41

SP - 1029

EP - 1038

JO - International Urology and Nephrology

JF - International Urology and Nephrology

SN - 0301-1623

IS - 4

ER -